Trial intelligence / Profile preview

Melatonin in COVID-19

IRCT20200506047323N5Phase 3Recruiting

Sponsor
Hormozgan University of Medical Sciences
Start
Aug 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of melatonin in coronavirus disease 2019 (COVID-19), sponsored by Hormozgan University of Medical Sciences. Started Aug 2020; status: recruiting.

02

Drugs

melatonin
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on IRCT20200506047323N5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200506047323N5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call